Jaguar Gene Therapy

Jaguar Gene Therapy

Biotechnology, 203 Mackenan Dr, Lake Forest, Illinois, 27511, United States, 51-200 Employees

jaguargenetherapy.com

  • facebook
  • LinkedIn

Who is JAGUAR GENE THERAPY

Jaguar Gene Therapy, LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases including those that impact sizeable patient popula...

Read More

map
  • 203 Mackenan Dr, Lake Forest, Illinois, 27511, United States Headquarters: 203 Mackenan Dr, Lake Forest, Illinois, 27511, United States
  • 2019 Date Founded: 2019
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 5063

checked-icon Does something look wrong? Fix it. | View contact records from JAGUAR GENE THERAPY

Jaguar Gene Therapy Org Chart and Mapping

Employees

Stephen Ollosi

Associate Director, Analytical Development

Will Jones

Vice President, Analytical Development and Qc

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Jaguar Gene Therapy

Answer: Jaguar Gene Therapy's headquarters are located at 203 Mackenan Dr, Lake Forest, Illinois, 27511, United States

Answer: Jaguar Gene Therapy's official website is https://jaguargenetherapy.com

Answer: Jaguar Gene Therapy's revenue is $10 Million to $25 Million

Answer: Jaguar Gene Therapy's SIC: 5063

Answer: Jaguar Gene Therapy has 51-200 employees

Answer: Jaguar Gene Therapy is in Biotechnology

Answer: Jaguar Gene Therapy contact info: Phone number: Website: https://jaguargenetherapy.com

Answer: Jaguar Gene Therapy, LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases including those that impact sizeable patient populations. The company is made up of a proven team of experts with unparalleled CMC (Chemistry, Manufacturing and Controls), regulatory, clinical and commercial acumen who have first-hand experience in bringing novel gene therapy treatments to patients and their families. Committed to patient safety and product purity, Jaguar is rapidly advancing an initial pipeline of three programs targeting: 1) Type 1 galactosemia; 2) a genetic cause of autism spectrum disorder and Phelan-McDermid syndrome and other severe neurodevelopmental disorders with a SHANK3 mutation or deletion; and 3) Type 1 diabetes. The company continues to evaluate opportunities to expand its pipeline using the strength of the team and close relationships with numerous academic institutions.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access